Literature DB >> 9004143

Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of the PMP22 gene.

V V Ionasescu1, C Searby, S A Greenberg.   

Abstract

A 32 year old woman with Dejerine-Sottas disease and negative family history is reported. Clinical onset of her condition was with congenital weakness of her distal four extremities, accompanied by peripheral facial nerve weakness, deafness, and nystagmus. She has used a wheelchair all her life. Sural nerve biopsy showed proliferation of Schwann cells, extensive endoneural fibrosis, axon loss, and demyelination. MNCVs showed marked slowing. MRI of the brain was normal. Molecular genetic studies indicated a de novo dominant missense point mutation of exon 3 of the peripheral myelin protein 22 gene at nucleotide 264 causing replacement of serine with leucine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9004143      PMCID: PMC1050822          DOI: 10.1136/jmg.33.12.1048

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  5 in total

1.  DNA duplication associated with Charcot-Marie-Tooth disease type 1A.

Authors:  J R Lupski; R M de Oca-Luna; S Slaugenhaupt; L Pentao; V Guzzetta; B J Trask; O Saucedo-Cardenas; D F Barker; J M Killian; C A Garcia; A Chakravarti; P I Patel
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

2.  The status of HMSN type III.

Authors:  A A Gabreëls-Festen; F J Gabreëls; F G Jennekens; T W Janssen-van Kempen
Journal:  Neuromuscul Disord       Date:  1994-01       Impact factor: 4.296

3.  De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III).

Authors:  K Hayasaka; M Himoro; Y Sawaishi; K Nanao; T Takahashi; G Takada; G A Nicholson; R A Ouvrier; N Tachi
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

4.  Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene.

Authors:  B B Roa; P J Dyck; H G Marks; P F Chance; J R Lupski
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

5.  Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene.

Authors:  V V Ionasescu; R Ionasescu; C Searby; R Neahring
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

  5 in total
  4 in total

1.  Charcot-Marie-Tooth type 1A disease caused by a novel Ser112Arg mutation in the PMP22 gene, coexisting with a slowly progressive hearing impairment.

Authors:  D Kabzińska; E Sinkiewicz-Darol; I Hausmanowa-Petrusewicz; A Kochański
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness.

Authors:  M J Kovach; J P Lin; S Boyadjiev; K Campbell; L Mazzeo; K Herman; L A Rimer; W Frank; B Llewellyn; E W Jabs; D Gelber; V E Kimonis
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.

Authors:  C Brancolini; P Edomi; S Marzinotto; C Schneider
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

4.  Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients.

Authors:  Na Young Jung; Hye Mi Kwon; Da Eun Nam; Nasrin Tamanna; Ah Jin Lee; Sang Beom Kim; Byung-Ok Choi; Ki Wha Chung
Journal:  Genes (Basel)       Date:  2022-07-08       Impact factor: 4.141

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.